Xtrackers FTSE CHINA 50 UCITS ETF Capitalisation 1C
Xtrackers FTSE CHINA 50 UCITS ETF Capitalisation 1C, trading under the ticker SG:HD8, is a compelling investment choice for those looking to capitalize on the economic dynamism of China's largest corporations. This Exchange Traded Fund (ETF) is meticulously designed to track the performance of the FTSE China 50 Index, which comprises the top 50 blue-chip companies listed in China. As such, it offers investors exposure to a selection of the country's most influential large-cap stocks, providing a comprehensive snapshot of China's corporate landscape.
Focusing on large-cap entities within a broad-based niche, this ETF encapsulates a strategic blend of stability and growth potential. Large-cap firms are typically characterized by their established market presence, financial strength, and consistent performance, making this ETF an attractive option for investors seeking to balance risk and reward in their portfolios. Moreover, the fund's broad-based approach ensures diversification across various sectors, minimizing sector-specific risks while maximizing opportunities for returns driven by China's economic expansion.
The Xtrackers FTSE CHINA 50 UCITS ETF is structured as a capitalisation fund, meaning it reinvests dividends to compound growth, aligning with long-term investment strategies. This feature is particularly appealing for investors focused on growth through reinvestment rather than immediate income. By integrating this ETF into their investment strategy, investors can gain strategic exposure to China's economic growth, tapping into the potential of its most robust and high-performing companies.
Xtrackers FTSE CHINA 50 UCITS ETF Capitalisation 1C (3007) Fund Flow Chart
Xtrackers FTSE CHINA 50 UCITS ETF Capitalisation 1C (3007) 1 year Net Flows: -46M
3007 ETF FAQ
What was HK:3007’s price range in the past 12 months?
HK:3007 lowest ETF price was 212.30 and its highest was 301.90 in the past 12 months.
What is the AUM of HK:3007?
As of Dec 04, 2025 The AUM of HK:3007 is 137.90M.
Is HK:3007 overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does HK:3007 pay dividends?
HK:3007 does not currently pay dividends.
How many shares outstanding does HK:3007 have?
Currently, no data Available
Which hedge fund is a major shareholder of HK:3007?
Currently, no hedge funds are holding shares in HK:3007